Ventracor "poised for success" with first third-generation centrifugal LVAD (left ventricle assist device)
This article was originally published in Clinica
Executive Summary
Flush after gaining an unexpected cash injection, Ventracor, the developer of the VentrAssist third-generation left ventricle assist device (LVAD), is pushing ahead with its plans to break into the US market and driving forward European sales of its product.